Date:12/29/2008

LUDE ANY STATEMENTS REGARDING BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS REGARDING THE FUTURE. EXCEPT FOR THE HISTORICAL INFORMATION PRESENTED HEREIN, MATTERS DISCUSSED IN THIS NEWS RELEASE CONTAIN FORWARD-LOOKING STATEMENTS THAT ARE SUBJECT TO CERTAIN RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH STATEMENTS. STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING STATEMENTS THAT ARE PRECEDED BY, FOLLOWED BY, OR THAT INCLUDE SUCH WORDS AS "ESTIMATE," "ANTICIPATE," "BELIEVE," "PLAN" OR "EXPECT" OR SIMILAR STATEMENTS ARE FORWARD- LOOKING STATEMENTS. RISKS AND UNCERTAINTIES FOR THE COMPANY INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS ASSOCIATED WITH THE RESEARCH AND DEVELOPMENT OF THE COMPANY'S THERAPEUTIC PIPELINE, INCLUDING RISKS RELATED TO EXECUTING PARTNERSHIPS TO PERFORM THE ADDITIONAL RESEARCH AND THE RESULTS OF ANY ADDITIONAL RESEARCH PERFORMED ON THE RECEPTOR BLOCKING COMPOUNDS, AS WELL AS RISKS ASSOCIATED WITH THE DEVICE DIVISION, INCLUDING RISKS RELATED TO SUPPLY AGREEMENTS FOR THE BIOREACTOR DEVICE . OTHER RISKS INCLUDE RISKS ASSOCIATED WITH THE REGULATORY APPROVAL PROCESS, COMPETITIVE PRODUCTS AND COMPANIES AND THE COMPANY'S ABILITY AND LEVEL OF SUPPORT FOR ITS RESEARCH AND DEVELOPMENT ACTIVITIES. THERE CAN BE NO ASSURANCE THAT THE COMPANY'S DEVELOPMENT EFFORTS WILL SUCCEED AND THE COMPANY WILL ULTIMATELY ACHIEVE COMMERCIAL SUCCESS. THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THIS NEWS RELEASE, AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS, AND INTENTIONS CONTAINED IN THIS NEWS RELEASE ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS, OR INTENTIONS WILL PROVE TO BE ACCURATE. INVESTORS SHOULD CONSID
'/>"/>

SOURCE CellCyte Genetics Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
2. Beta Release of a New Genetics Website- ItRunsInMyFamily.com
3. PTSD Risk Rooted in Stress and Genetics
4. Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nations Premier High School Science Competition
5. Understanding donor-recipient genetics could decrease early kidney transplant complications
6. Lung Cancer Genetics Different in Black Patients: Study
7. Genetics of aging and cancer resistance
8. Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery
9. New technique to study the genetics of breast cancer
10. Know the Myths and Facts About Family Health History: American College of Medical Genetics
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results